Literature DB >> 3117398

Size and location of tumors influencing the effect of bladder instillation therapy.

H Watanabe1, M Nakao, S Nakagawa, H Takada.   

Abstract

The clinical results obtained in 81 cases of bladder tumor are used as a basis for discussion of factors influencing the effect of bladder instillation therapy. The following conclusions are derived: 1) If bladder instillation therapy aims only at complete remission (CR), tumors over 1 cm in diameter should be excluded, because this is the theoretical size limit beyond which instillation therapy cannot lead to CR. 2) At least 40 ml of drugs may be needed for instillation therapy for tumors located in area B, the limited part posterior to the trigonum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117398     DOI: 10.1007/bf00262485

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  4 in total

1.  Adriamycin instillation therapy for bladder tumors.

Authors:  T Mishina; T Fujiwara; K Miyakoda; H Araki; T Kobayashi; M Saitoh; H Watanabe
Journal:  Tohoku J Exp Med       Date:  1979-04       Impact factor: 1.848

Review 2.  Absorption of anticancer drugs through bladder epithelium.

Authors:  T Mishina; H Watanabe; T Kobayashi; M Maegawa; M Nakao; S Nakagawa
Journal:  Urology       Date:  1986-02       Impact factor: 2.649

3.  Mitomycin C bladder instillation therapy for bladder tumors.

Authors:  T Mishina; K Oda; S Murata; H Ooe; Y Mori
Journal:  J Urol       Date:  1975-08       Impact factor: 7.450

4.  Cytosine arabinoside bladder instillation therapy for bladder tumors.

Authors:  H Araki; T Mishina; K Miyakoda; T Fujiwara; T Kobayashi
Journal:  Tohoku J Exp Med       Date:  1982-01       Impact factor: 1.848

  4 in total
  1 in total

1.  Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.

Authors:  M G Wientjes; R A Badalament; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.